JP2020535815A5 - - Google Patents

Download PDF

Info

Publication number
JP2020535815A5
JP2020535815A5 JP2020518013A JP2020518013A JP2020535815A5 JP 2020535815 A5 JP2020535815 A5 JP 2020535815A5 JP 2020518013 A JP2020518013 A JP 2020518013A JP 2020518013 A JP2020518013 A JP 2020518013A JP 2020535815 A5 JP2020535815 A5 JP 2020535815A5
Authority
JP
Japan
Prior art keywords
polypeptide
rodent
nucleic acid
chimeric
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020518013A
Other languages
English (en)
Japanese (ja)
Other versions
JP7242650B2 (ja
JP2020535815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/053099 external-priority patent/WO2019067706A1/en
Publication of JP2020535815A publication Critical patent/JP2020535815A/ja
Publication of JP2020535815A5 publication Critical patent/JP2020535815A5/ja
Priority to JP2023035499A priority Critical patent/JP7534465B2/ja
Application granted granted Critical
Publication of JP7242650B2 publication Critical patent/JP7242650B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020518013A 2017-09-29 2018-09-27 ヒト化C1q複合体を発現する非ヒト動物 Active JP7242650B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023035499A JP7534465B2 (ja) 2017-09-29 2023-03-08 ヒト化C1q複合体を発現する非ヒト動物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762565438P 2017-09-29 2017-09-29
US62/565,438 2017-09-29
PCT/US2018/053099 WO2019067706A1 (en) 2017-09-29 2018-09-27 NON-HUMAN ANIMALS EXPRESSING A HUMANIZED C1Q COMPLEX

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023035499A Division JP7534465B2 (ja) 2017-09-29 2023-03-08 ヒト化C1q複合体を発現する非ヒト動物

Publications (3)

Publication Number Publication Date
JP2020535815A JP2020535815A (ja) 2020-12-10
JP2020535815A5 true JP2020535815A5 (cg-RX-API-DMAC7.html) 2021-11-04
JP7242650B2 JP7242650B2 (ja) 2023-03-20

Family

ID=63858187

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020518013A Active JP7242650B2 (ja) 2017-09-29 2018-09-27 ヒト化C1q複合体を発現する非ヒト動物
JP2023035499A Active JP7534465B2 (ja) 2017-09-29 2023-03-08 ヒト化C1q複合体を発現する非ヒト動物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023035499A Active JP7534465B2 (ja) 2017-09-29 2023-03-08 ヒト化C1q複合体を発現する非ヒト動物

Country Status (18)

Country Link
US (2) US11186848B2 (cg-RX-API-DMAC7.html)
EP (2) EP4249502A3 (cg-RX-API-DMAC7.html)
JP (2) JP7242650B2 (cg-RX-API-DMAC7.html)
KR (2) KR20240128129A (cg-RX-API-DMAC7.html)
CN (2) CN116376973A (cg-RX-API-DMAC7.html)
AU (1) AU2018341685A1 (cg-RX-API-DMAC7.html)
CA (1) CA3077418A1 (cg-RX-API-DMAC7.html)
DK (1) DK3687287T5 (cg-RX-API-DMAC7.html)
ES (1) ES2961713T3 (cg-RX-API-DMAC7.html)
FI (1) FI3687287T3 (cg-RX-API-DMAC7.html)
IL (1) IL273588A (cg-RX-API-DMAC7.html)
LT (1) LT3687287T (cg-RX-API-DMAC7.html)
PT (1) PT3687287T (cg-RX-API-DMAC7.html)
RU (1) RU2020112751A (cg-RX-API-DMAC7.html)
SG (1) SG11202002002XA (cg-RX-API-DMAC7.html)
SI (1) SI3687287T1 (cg-RX-API-DMAC7.html)
WO (1) WO2019067706A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202001389B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019067875A1 (en) 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS AND METHODS OF USE
WO2020247452A1 (en) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082546A1 (en) * 1996-11-06 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
DK1407017T3 (en) * 2000-11-07 2009-09-21 Zymogenetics Inc Human receptor for tumor nekrose faktor
US20040248156A1 (en) * 2001-12-03 2004-12-09 Tianhua Hu Methods and materials relating to novel C1q domain-containing polypeptides and polynucleotides
GB0322998D0 (en) * 2003-10-01 2003-11-05 Ares Trading Sa Protein
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
CN101330925A (zh) * 2005-12-16 2008-12-24 瑞泽恩制药公司 用d114拮抗剂抑制肿瘤生长的治疗方法
HRP20150086T1 (xx) * 2007-06-12 2015-02-27 Ac Immune S.A. Humanizirana antitijela za beta amiloid
PL3248462T3 (pl) * 2010-03-31 2024-07-08 Ablexis, Llc Modyfikacja myszy metodami inżynierii genetycznej w celu wytworzenia przeciwciał chimerycznych
CN103380145B (zh) * 2010-12-17 2016-10-12 生物控股有限公司 人类抗-sod1抗体
US9043996B2 (en) * 2011-10-28 2015-06-02 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex animals
KR102295746B1 (ko) * 2011-10-28 2021-09-01 리제너론 파아마슈티컬스, 인크. 유전자 변형된 주요 조직적합성 복합체 마우스
US9801362B2 (en) * 2012-03-16 2017-10-31 Regeneron Pharmaceuticals, Inc. Non-human animals expressing pH-sensitive immunoglobulin sequences
FR2996561B1 (fr) * 2012-10-09 2016-03-18 Commissariat Energie Atomique Procede de preparation de proteine c1q recombinante
MX2015010841A (es) 2013-02-20 2016-05-09 Regeneron Pharma Modificacion genetica de ratas.
DK3456831T3 (da) 2013-04-16 2021-09-06 Regeneron Pharma Målrettet modifikation af rottegenom
SG11201510316UA (en) * 2013-07-09 2016-01-28 Annexon Inc Anti-complement factor c1q antibodies and uses thereof
MX2016014504A (es) * 2014-05-05 2017-05-23 Regeneron Pharma Animales c5 y c3 humanizados.
BR112017010793A2 (pt) * 2014-11-24 2017-12-26 Regeneron Pharma animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo.
WO2019067875A1 (en) 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS AND METHODS OF USE

Similar Documents

Publication Publication Date Title
JP7526227B2 (ja) ヒト化sirpa-il15ノックインマウス及びその使用方法
KR101238074B1 (ko) c-MET 키나제 결합 단백질
KR102617691B1 (ko) 인간화 분화 클러스터 47 유전자를 가진 비인간 동물
CN110996658B (zh) 包含人源化asgr1基因座的非人动物
JP2024091951A (ja) 操作された重鎖可変領域を有する齧歯類
KR102466092B1 (ko) 결손 p450 산화환원효소를 갖는 인간 간 키메라 비인간 동물 및 이를 이용하는 방법
Wang et al. Evidence of IgY subclass diversification in snakes: evolutionary implications
JP7117088B2 (ja) 抗体及びその製造方法、並びに抗体の熱安定性を向上させる方法
EP1811023A1 (en) Gene expressed specifically in es cells and utilization of the same
CN112920272A (zh) 抗cTnI的蛋白和检测cTnI的方法
Angsujinda et al. Development of a lateral flow assay for rapid and accurate detection of chicken anemia virus
WO2019067706A4 (en) Non-human animals expressing humanized c1q complex
US20230232796A1 (en) Non-human animals comprising a humanized ace2 locus
US11878065B2 (en) Reporter protein fused antibodies
US20150307949A1 (en) Identification and eradication of insect pests
US11332720B2 (en) Murine parvovirus and uses thereof
CN112979798A (zh) 一种包含c反应蛋白抗原结合结构域的分离的结合蛋白
KR102166717B1 (ko) 세파로토신을 포함하는 연체동물의 번식 촉진용 조성물
Takahashi et al. Identification of the cell-type-specific ER membrane protein Tanmp expressed in hypothalamic tanycytes and subsets of neurons
Moore The Role of Twisted Gastrulation in the Extracellular Regulation of Bone Morphogenetic Protein Signalling
RU2822370C2 (ru) Гуманизированные мыши с нокином sirpa-il15 и способы их использования
CN120112164A (zh) 包含修饰的转铁蛋白受体基因座的非人动物
Jolly et al. MKPV (aka MuCPV) and related chapparvoviruses are nephro-tropic and encode novel accessory proteins p15 and NS2
KR20090052976A (ko) 위의 기능에 관여하는 위 조직 특이적 유전자phs11s15230
KR20090052972A (ko) 위의 기능에 관여하는 위 조직 특이적 유전자pmm7sx07710